Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Coherus Oncology, Inc. - Common Stock
(NQ:
CHRS
)
1.450
+0.010 (+0.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Coherus Oncology, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Coherus Oncology to Participate in Upcoming Investor Conferences
October 23, 2025
From
Coherus Oncology, Inc.
Via
GlobeNewswire
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals
↗
October 10, 2025
4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.
Via
Benzinga
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 03, 2025
– CHS-114, an anti-CCR8 cytolytic antibody, will also be featured in SITC’s upcoming webinar series “Targets for Cancer IO: A Deep Dive” on October 22, 2025 –
From
Coherus Oncology, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Insights Ahead: Coherus BioSciences's Quarterly Earnings
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
Earnings Preview: Coherus BioSciences
↗
May 09, 2025
Via
Benzinga
This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
↗
September 04, 2025
Via
Benzinga
Coherus Oncology to Participate in Upcoming Investor Conferences
September 03, 2025
From
Coherus Oncology, Inc.
Via
GlobeNewswire
Coherus (CHRS) Q2 Revenue Jumps 10%
↗
August 07, 2025
Via
The Motley Fool
Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
August 07, 2025
From
Coherus Oncology, Inc.
Via
GlobeNewswire
Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025
July 31, 2025
From
Coherus Oncology, Inc.
Via
GlobeNewswire
Which stocks are moving after the closing bell on Friday?
↗
July 04, 2025
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 03, 2025
Via
Benzinga
Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
May 27, 2025
– First patient dosed in a Phase 1b/2 study evaluating STC-15, a METTL3 inhibitor, in combination with LOQTORZI, a next-generation PD-1 inhibitor –
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Top movers in Friday's after hours session
↗
May 23, 2025
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
Which stocks are moving before the opening bell on Tuesday?
↗
May 13, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 13, 2025
Via
Benzinga
Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus to Report First Quarter 2025 Financial Results on May 12, 2025
May 05, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus to Participate in Upcoming Investor Conferences
May 01, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025
April 28, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Which stocks are moving after the closing bell on Wednesday?
↗
April 16, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
April 14, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes
April 01, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual Meeting
March 25, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update
March 10, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 10, 2025
↗
March 10, 2025
Via
Benzinga
Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025
March 03, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference
February 24, 2025
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
